UNDERSTANDING SYRINGE EXCHANGE IN UTAH. Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW

Similar documents
Advocating for Syringe Exchange Programs

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

Targeted Outreach & Other Strategies for Increasing HCV Testing

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Hepatitis B Virus and the Opioid Crisis

Syringe Exchange Programs December 2005

Albuquerque Health Care for the Homeless (AHCH)

As a result of this training, participants will be able to:

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

As a result of this training, participants will be able to:

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Drug Use, Harm Reduction, and HIP

Historical Perspectives

Guidelines For Services Providing Injecting Equipment

INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT

who use drugs in order to assist them in reducing harm while in the cycle of addiction

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Aligning Pain Management Community Public Health Presentation

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Amanda Archer, BS, MPH

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

What s The Point? The unique role of pharmacists in HIV/HCV. prevention efforts BAY AREA AND NORTH COAST AREA APRIL 30, 2016

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

Prevention Point Philadelphia

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences

Opioid Task Force Kick-Off Meeting. February 29, 2016

Needle Exchange Programs

Advocating for Sensible Policies in the Age of HCV Cure

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Syringe Exchange Programs: Getting Started

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

Local Legislative Approval and Program Certification

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

SYRINGE SERVICES PROGRAMS IN INDIANA

What is injection drug use?

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

End the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN

Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis

State Opioid Response (SOR) Grant

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

Practical Solutions to Reduce Incidence of Liver Cancer. Nancy Steinfurth, Executive Director Liver Health Connection November 2017

Additional North Carolina Projects

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department

The Syndemics of HIV, Hepatitis, and Overdose

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW

A Community Response to a Community Crisis

Successful Prevention Strategies to Address the Opioid Crises

State and Local Policies Regarding IDUs' Access to Sterile Syringes December 2005

Transmission/Prevention

Project Connections Buprenorphine Program

Promoting hepatitis B vaccination

Part 1: Introduction & Overview

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

LIFEPOINT Outreach & Syringe Exchange Program

National Viral Hepatitis Action Plan Priority Populations Approach

CPAA Opioid Response Workgroup Meeting

Becoming a harm reduction distribution agency in Toronto - information session

CDC s Response to the Viral Hepatitis/Opioid Syndemic

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner

Opioid Abuse. in Rural Minnesota. County Farm Bureau Resource Guide

Hospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia,

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Rural Prevention and Treatment of Substance Abuse Toolkit

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

Understanding the Opiate Epidemic

COMMUNITY ASSESSMENT OF THE OPIOID CRISIS IN LORAIN COUNTY, OHIO EXECUTIVE SUMMARY

Harm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN

The Emerging Science of E-Cigarette Use and Nicotine Addiction

Strategic Plan

Syringe Exchange Program Plan

Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles

HIV Prevention, Hepatitis Programming, and Drug User Health An Integrated Service Model at SFDPH. Protecting and Promoting Health and Equity

Needle and syringe distribution

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

HIV AND PEOPLE WHO INJECT DRUGS

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

Hepatitis C and Innovative Public Health Practice

Australian Injecting and Illicit Drug Users League. Policy Position Paper 8 Retractable Syringes

A summary guide for HIV prevention peer programming for street based sex workers

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?

Ending HIV/AIDS Among Injection Drug Users in Minnesota

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT

QuADS Organisational Standards and Professional Competencies in needle exchange

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Available In person Courses

Innovative Ways to Fund Harm Reduction Services New Mexico

Transcription:

UNDERSTANDING SYRINGE EXCHANGE IN UTAH Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW

COMMUNITY NEEDS ASSESSMENT OF PEOPLE WHO INJECT DRUGS (PWID) IN SALT LAKE CITY, UTAH Authors: Amelia Prebish, MPH; Emma Sawyer, MPH; Chad VanSant-Webb, MPH; Colette McAfee, PhD, MPH

PURPOSE & RESEARCH OBJECTIVES Purpose of Research: Conduct a community needs assessment of both current and former PWID in Salt Lake City, to develop a better understanding of what is needed for the program to be successful and benefit the community. Research Objectives: 1. Assess risk behaviors 2. Identify needs for SEP location and services 3. Identify barriers to SEPs

METHODS Cross-sectional descriptive study Snowball sampling Data collected via paper and online surveys from: Shelters Substance abuse programs Community health clinics Referrals Incentive to participate

PROTECTION OF HUMAN SUBJECTS Anonymous survey Consent form Survey participant could not be severely impaired Reduction of stigmatization

BREAKDOWN OF PARTICIPANTS 340 Survey Participants 211(62.1%) History of IDU 112 (33.0%) No History of IDU 17 (5.0%) N/A 59 (28.0%) Current Users 152 (72.0%) Former Users

85.2% (n=281) understanding of disease transmission No significant differences when compared to age, gender, race/ethnicity, level of education, or injection drug use status RESULTS: HIV/HCV KNOWLEDGE

RESULTS: RISK BEHAVIORS OF PWID Shared paraphernalia in last 60 days (31.9%) Use new syringes: never or sometimes (54.6%) Do not clean syringes for re-use (22.7%) Clean syringes for re-use (71.6%)

Fear of law enforcement (52.5%) RESULTS: BARRIERS TO USING SEP Distance to service (34.2%) Jail or prison in last 90 days (X²(1, N=190)=4.78, p=.029) No significant difference in reported barriers between whites and people of color

Would use service (83.2%) RESULTS: SEP LOCATIONS AND SERVICES Would return used syringes (87.0%) Use SEP daily (52.1%) Use SEP weekly (27.6%)

CONCLUSION Sharing syringes Cleaning syringes for reuse Fear of law enforcement No matter what type, people want this service

SYRINGE EXCHANGE IN UTAH Heather Bush Syringe Exchange Program Coordinator Utah Department of Health

WHAT IS SYRINGE EXCHANGE? More than just exchanging syringes! Its all about the CONNECTION! A community-based public health program that provides comprehensive harm reduction services such as : Sterile needles, syringes, and other injection equipment Safe disposal containers for needles and syringes HIV and hepatitis testing and linkage to treatment Education about overdose prevention and safer injection practices Referral to substance use disorder treatment, including medication-assisted treatment Referral to medical, mental health, and social services Tools to prevent HIV, STDs, and viral hepatitis including counseling, condoms, and vaccinations And so much more: Reaches people where they are with what they need to reduce the harms associated with drug use. Reaches people who may not otherwise access services Without judgement, stigma, shoulds/should nots Provide referrals, support, education, linkages and CONNECTION!

DOES NOT INCREASE, ENCOURAGE OR CONDONE DRUG USE DOES DECREASE HIV AND HEPATITIS C TRANSMISSION DOES PROVIDE ACCESS TO OVERDOSE PREVENTION/NALOXONE DOES REDUCE ACCIDENTAL NEEDLE STICKS DOES REDUCE OTHER INJECTION DRUG RELATED HEALTH ISSUES AND HEALTH CARE COSTS SYRINGE EXCHANGE MYTHS

SYRINGE EXCHANGE IS HARM REDUCTION Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. Harm Reduction is also a movement for social justice built on a belief in, and respect for, the rights of people who use drugs. Harm reduction incorporates a spectrum of strategies from safer use, to managed use to abstinence to meet drug users where they re at, (but doesn t leave them there!) addressing conditions of use along with the use itself.

Both HIV and HCV are transmitted blood to blood HIV AND HEPATITIS C TRANSMISSION Both are transmitted by sharing injection drug use equipment including: Needles and syringes Cookers Cotton Water Tourniquet Surface Non-injection Equipment: Cocaine straws, tooters Pipes Other Needle sharing Tattoos Piercings

SYRINGE EXCHANGE IS HIV & HCV PREVENTION Past or current injection drug use is the most important risk factor for HCV infection. 3 US Preventive Services Task Force With an estimated 34,000 new HCV infections in the United States in 2015, new infections have nearly tripled in the past 5 years, reaching a 15-year high. 2,4,* ~3.5 million people living with chronic HCV in the United States 2 ~60% are current or former PWIDs 3 The average age at first heroin use is 25.4 years.

SYRINGE EXCHANGE IS HIV/HCV PREVENTION Viral Factors HIV, hepatitis C (HCV) and hepatitis B (HBV) are transmitted from one person to another by blood from an infected person getting into the blood stream of another. Injection drug use is the most common way people get hepatitis C, by sharing any equipment that may have come in contact with someone s blood while injecting HCV can survive outside the body on inanimate surfaces, cookers, and filters for days, and can last even longer in the barrel of a syringe In controlled healthcare environments, HCV is transmitted at up to a 10-fold rate relative to HIV following needlesticks Risk estimates show that the average chance that an HIV-negative person will get HIV each time that person shares needles to inject drugs with an HIV-positive person is about 1 in 160. IDU can cause other diseases and complications Host & Societal Factors Sharing needles, syringes, and other injection equipment are common among PWID Injecting drugs can reduce inhibitions and increase sexual risk behaviors The epidemic of prescription opioid misuse and abuse has led to increased numbers of PWID Individuals using prescription drugs nonmedically may turn to injection as a more efficient method of drug delivery Heroin use has increased dramatically nationwide in the past several years. Social and economic factors limit access to HIV and HCV prevention and treatment services among PWID Stigma and discrimination are associated with illicit substance use.

HCV & HIV OUTBREAKS ASSOCIATED WITH IDU ARE OCCURRING THROUGHOUT THE UNITED STATES CDC, Centers for Disease Control and Prevention.

SYRINGE EXCHANGE IS OVERDOSE PREVENTION Syringe exchange provides information on: Preventing overdose Recognizing an overdose Responding to an overdose Administering naloxone Reaches end users and their friends and family THE REALITY BEHIND UTAH S ADDICTION 7TH 7 TH - UTAH HAS THE SEVENTH HIGHEST DRUG OVERDOSE RATE IN THE U.S. 80% 80% OF HEROIN USERS STARTED WITH PRESCRIPTION OPIOIDS 6 6 UTAHNS DIE EVERY WEEK FROM OPIOID OVERDOSE

The CDC reports In many areas around the country, the populations newly infected with HCV are strongly linked to those affected by the opioid crisis, mostly young, white men in rural counties. People with HCV who use alcohol or other drugs have much higher rates of liver disease and death than those who are not using. Clinical recommendations suggest that everyone diagnosed with HCV should receive curative treatment, only a fraction of these individuals are currently eligible due sobriety restrictions. In order to eliminate HCV, we must identify, test and treat active PWID. People who have been incarcerated or in substance abuse treatment are at much higher risk of overdose and engaging in risky behaviors (sharing or high risk sex) after release. HEPATITIS C AND OPIATE EPIDEMICS MUST BE ADDRESSED TOGETHER

UTAH SYRINGE EXCHANGE LAW Agencies in Utah may operate a syringe exchange program in the state to prevent the transmission of disease and reduce morbidity and mortality among individuals who inject drugs and those individuals contacts and collect data to prove effectiveness and show that SEPs do not increase drug use. Utah Syringe Exchange Law requires any SEP to provide: Clean, new syringes for free Collect and properly dispose of used syringes Information and referrals: HIV and HCV prevention and testing Substance abuse treatment Overdose prevention and access to Naloxone Agencies who choose to conduct syringe exchange must with UDOH and comply will the administrative rule and provide aggregate data to UDOH on quarterly basis. UDOH mandated to report to Utah State Legislature annually.

COMPREHENSIVENESS OF STATE LAWS PERTINENT TO PREVENTION OF HCV INFECTION AMONG PWIDS, US 2016 Most comprehensive More comprehensive Moderate Less comprehensive Least comprehensive Assessment of whether a state had established Authorization of syringe exchange statewide or in selected jurisdictions Exemption of needles or syringes from the definition of drug paraphernalia Decriminalization of possession and distribution of syringes or needles for participants of a legally authorized syringe service program Avoidance of criminal prosecution for possession of drug paraphernalia by disclosing possession of a needle or sharp object to an arresting officer Allowance for the retail sale of syringes without a prescription to PWIDs Campbell CA, et al. MMWR Morb Mortal Wkly Rep. 2017;66(18):465-469.

CURRENTLY ENROLLED SEPS Utah Harm Reduction Coalition Downtown SLC- mobile outreach Sandy fixed site 2x/week Tooele mobile delivery 1x/week Ogden 1x week ONE Voice Recovery Outreach/Mobile SLC Utah Naloxone Support SEPs with Naloxone and training Salt Lake County Health Department Syringe Collection, disposal Naloxone Utah AIDS Foundation Fixed Site HIV/HCV/STD Testing

UTAH DEPARTMENT OF HEALTH ROLE Administer SEP and Opiate Overdose Laws Collect, analyze and report data from SEPs and Overdose Prevention Providers Provide support, technical assistance and capacity building Develop support and resource materials Identify funding opportunities Provide training opportunities with quality and consistency across the state Identify community resources Facilitate communication and collaboration among Utah agencies Provide community education Provide SEP supplies and naloxone when available Receive training, technical assistance and consultation from national and other state s programs. Address policy around state

REFERENCES The contribution of health risk behaviours to excess mortality in American adults with chronic hepatitis C: A population cohort-study, Authors: H. Innes,A. McAuley,M. Alavi,H. Valerio,D. Goldberg,S.J. Hutchinson Hepatitis C Virus outbreak among millennials, Capitol Weekly, August 17, 2017 National Viral Hepatitis Roundtable, Hepatitis C: The State of Medicaid Access, 2016 National Academies of Sciences, Engineering, and Medicine;A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report (2017); Gillian J. Buckley and Brian L. Strom, Editors Determination That a Demonstration Needle Exchange Program Would be Effective in Reducing Drug Abuse and the Risk of Acquired Immune Deficiency Syndrome Infection Among Intravenous Drug Users HHS Notice February 2011 Surgeon General s Report on Alcohol, Drugs, and Health, November 2016. CDC: Syringe Services Programs Fact Sheet, https://www.cdc.gov/hiv/risk/ssps.html

HOW SYRINGE EXCHANGE WORKS Mindy Vincent, LCSW Utah Harm Reduction Coalition

WHO WE ARE The Utah Harm Reduction Coalition (UHRC) is a non-profit community based organization providing harm reduction services, education, and advocacy throughout the state of Utah. Our mission is to provide evidence based interventions to aid people in reducing health and social harms associated with substance use.

Utah Harm Reduction Coalition was founded in July 2016 First legal provider of syringe exchange services in Utah WHO WE ARE. We are the largest provider, serving more than 500 with 2000 syringe exchange encounters per month We have exchange activities in Salt Lake County, Weber County and Tooele County and will be starting exchanges soon in Utah, Carbon and Emery Counties.

YOU GIVE THEM WHAT? Items Distributed Tourniquets Cookers and Twist Tie Cottons Alcohol Pads Condoms Triple Antibiotic Ointment Personal Sharps Container Why do they need that? We are first and foremost trying to prevent the spread of diseases such as HIV and HCV We are also trying to help prevent drug related injury such as abscess, endocarditis, sepsis, cotton fever and soft tissue damage, just to name a few

Risks of Re-using Syringes 1,000 Words The pits can hold blood, tissue, and micro-organisms. This increases the risk for infections and the transmission of blood-borne pathogens. Pieces of the metal can flake off in the injection site. The bent tip creates a more jagged puncture point, resulting in more tissue damage and longer healing times. Bacteria from skin and surfaces

YOU GIVE THEM WHAT? Naloxone and overdose prevention education Free HIV and HCV testing and prevention information Access to substance abuse assessments, treatment, detox, medical care, recovery support and much more Most of all we give them LOVE and HOPE!

HOW IT WORKS Participants enroll by completing an interview with demographic information, drug use and sharing history, HIV/HCV risk assessment and other information. All information is kept strictly confidential and used to inform and improve syringe exchange activities Participants are assigned a code that is easy to remember and they are able to use at any exchange location. Participants must turn in at least 1 syringe to exchange We use 1 for 1 Plus Model- working toward a 1 for 1 Plus Enhanced Model Participants may get up to 30 syringes on their first enrollment Participants must report what they are doing with their syringes if they are not turning them in to us.

Drop in counseling Clinical Groups Healthy Living Classes (including safer injection) Non abstinence based recovery support groups Motivational Interviewing DBT Seeking Safety REBT Shame Resiliency Good old fashioned case management IS SYRINGE EXCHANGE SUBSTANCE ABUSE TREATMENT?

BARRIERS Law Enforcement concerns Stigma drug use, homelessness, etc Fear and misunderstanding Lack of compassion Lack of clarity in the law Conflict with drug paraphernalia law Disposal vs. Distribution

WHAT WE ARE DOING TO OVERCOME Gain support - Continue to build allies throughout the state Education and Awareness - Educational Town Hall meetings, presentation, social media, Community service - UHRC does multiple clean ups per week Meet in the middle Assess and identify community needs and readiness

SYRINGE EXCHANGE ACTIVITY DECEMBER 1, 2016 -JUNE 30, 2017 8230 1762 68784 Return Ratio 2.29 180197 Syringes collected Syringes distributed Clean ups Disposed elsewhere

PARTNERSHIPS Utah Department of Health Youth Futures Salt Lake Co Health Department Downtown Alliance 4 th St. Clinic Utah AIDS Foundation One Voice Recovery Metamorphosis Southeast Health Department Acqua Recovery Weber Human Services Northern Utah Coalition Wasatch Co. Health A&D Psychotherapy VOA Ogden Regional Midtown Clinic Twilight Concert Series Weber/Morgan Health Department Clean Team Daylight Recovery Tooele County Health Dept True North Treatment Center AND MANY MORE!

CONTACT INFORMATION Amelia Prebish Health Program Specialist II Utah Department of Health 801-538-6256 amprebish@utah.gov health.utah.gov/epi opidemic.org Heather Bush Syringe Exchange Program Coordinator Utah Department of Health 801-538-6194 Hbush@Utah.gov syringeexchange@utah.gov FACEBOOK: @UtahSEN Health.Utah.gov/epi/prevention Mindy Vincent